NO20041070L - Preparat for behandling av vanlig forkjolelse. - Google Patents

Preparat for behandling av vanlig forkjolelse.

Info

Publication number: NO20041070L
Authority: NO; Norway
Prior art keywords: preparation; treatment; salt; combination; common colds
Prior art date: 2001-09-18

Application number

NO20041070A

Other languages

English (en)

Other versions

NO334441B1 (no

Inventor

Hanne Anette Moesgaard

Karin Lowenstein Christensen

Original Assignee

Nycomed Danmark Aps

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-18

Filing date

2004-03-12

Publication date

2004-05-18

2004-03-12 Application filed by Nycomed Danmark Aps filed Critical Nycomed Danmark Aps

2004-05-18 Publication of NO20041070L publication Critical patent/NO20041070L/no

2014-03-03 Publication of NO334441B1 publication Critical patent/NO334441B1/no

Links

201000009240 nasopharyngitis Diseases 0.000 title abstract 2
239000000203 mixture Substances 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 2
YGWFCQYETHJKNX-UHFFFAOYSA-N 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1h-imidazol-3-ium;chloride Chemical compound [Cl-].CC1=CC(C(C)(C)C)=CC(C)=C1CC1=NCC[NH2+]1 YGWFCQYETHJKNX-UHFFFAOYSA-N 0.000 abstract 1
208000036071 Rhinorrhea Diseases 0.000 abstract 1
206010039101 Rhinorrhoea Diseases 0.000 abstract 1
239000000812 cholinergic antagonist Substances 0.000 abstract 1
OEXHQOGQTVQTAT-JRNQLAHRSA-N ipratropium Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)[N@@+]2(C)C(C)C)C(=O)C(CO)C1=CC=CC=C1 OEXHQOGQTVQTAT-JRNQLAHRSA-N 0.000 abstract 1
229960001888 ipratropium Drugs 0.000 abstract 1
210000002850 nasal mucosa Anatomy 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1
239000005526 vasoconstrictor agent Substances 0.000 abstract 1
229960001095 xylometazoline hydrochloride Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Saccharide Compounds (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Polyurethanes Or Polyureas (AREA)
Cosmetics (AREA)
Orthopedics, Nursing, And Contraception (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO20041070A 2001-09-18 2004-03-12 Preparat for behandling av vanlig forkjølelse. NO334441B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200101356		2001-09-18
PCT/IB2002/003828 WO2003024433A2 (en)	2001-09-18	2002-09-18	Compositions for treatment of common cold, comprising ipratropium and xylometazoline

Publications (2)

Publication Number	Publication Date
NO20041070L true NO20041070L (no)	2004-05-18
NO334441B1 NO334441B1 (no)	2014-03-03

Family

ID=8160714

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20041070A NO334441B1 (no)	2001-09-18	2004-03-12	Preparat for behandling av vanlig forkjølelse.

Country Status (20)

Country	Link
US (2)	US7652030B2 (no)
EP (2)	EP1661570A3 (no)
JP (1)	JP4500045B2 (no)
KR (1)	KR100810872B1 (no)
CN (1)	CN1290502C (no)
AT (1)	ATE318601T1 (no)
BR (1)	BRPI0212586B8 (no)
CA (1)	CA2460140C (no)
DE (1)	DE60209511T2 (no)
DK (1)	DK1446119T3 (no)
EA (1)	EA008165B1 (no)
ES (1)	ES2259098T3 (no)
HU (1)	HU226527B1 (no)
MX (1)	MXPA04002500A (no)
NO (1)	NO334441B1 (no)
NZ (1)	NZ531792A (no)
PL (1)	PL208686B1 (no)
PT (1)	PT1446119E (no)
SI (1)	SI1446119T1 (no)
WO (1)	WO2003024433A2 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
DE60209511T2 (de) *	2001-09-18	2006-10-05	Nycomed Danmark Aps	Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten
TWI359675B (en) *	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
AU2005210086A1 (en) *	2004-02-06	2005-08-18	Meda Pharma Gmbh & Co. Kg	Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005084330A2 (en) *	2004-03-02	2005-09-15	Synergia Pharma, Inc.	Compositions and methods for treating nasal congestion
DE102004049008A1 (de) *	2004-10-05	2006-04-06	Merck Patent Gmbh	Neue Verwendung für α-Sympathomimetika mit 2-Imidazolinstruktur
CA2592605C (en) *	2004-12-27	2010-12-07	Eisai R&D Management Co., Ltd.	Method for stabilizing anti-dementia drug
DE102006023770A1 (de) *	2006-05-20	2007-11-22	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Treibgasfreie Aerosolformulierung für die Inhalation
EP2077132A1 (en)	2008-01-02	2009-07-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Dispensing device, storage device and method for dispensing a formulation
US20090270472A1 (en) *	2008-04-25	2009-10-29	Kenneth Gould	Method to use oxymetazoline to interrupt the development of the common cold syndrome
EP2414560B1 (de)	2009-03-31	2013-10-23	Boehringer Ingelheim International GmbH	Verfahren zur beschichtung einer oberfläche eines bauteils
EP2432531B1 (de)	2009-05-18	2019-03-06	Boehringer Ingelheim International GmbH	Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es)	2009-11-25	2012-06-14	Boehringer Ingelheim Int	Nebulizador.
US10016568B2 (en)	2009-11-25	2018-07-10	Boehringer Ingelheim International Gmbh	Nebulizer
WO2011064163A1 (en)	2009-11-25	2011-06-03	Boehringer Ingelheim International Gmbh	Nebulizer
EP2585151B1 (en)	2010-06-24	2018-04-04	Boehringer Ingelheim International GmbH	Nebulizer
WO2012130757A1 (de)	2011-04-01	2012-10-04	Boehringer Ingelheim International Gmbh	Medizinisches gerät mit behälter
US9827384B2 (en)	2011-05-23	2017-11-28	Boehringer Ingelheim International Gmbh	Nebulizer
WO2013152894A1 (de)	2012-04-13	2013-10-17	Boehringer Ingelheim International Gmbh	Zerstäuber mit kodiermitteln
EP2978407B1 (en) *	2013-03-29	2020-05-06	Santa Farma Ilaç Sanayi A.S.	Aqueous solution composition containing ipratropium and oxymetazoline
WO2014158118A1 (en) *	2013-03-29	2014-10-02	Santa Farma İlaç Sanayi̇ A.Ş.	Suspension composition containing ipratropium and oxymetazoline
JP6643231B2 (ja)	2013-08-09	2020-02-12	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	ネブライザ
EP2835146B1 (en)	2013-08-09	2020-09-30	Boehringer Ingelheim International GmbH	Nebulizer
WO2015054359A1 (en) *	2013-10-08	2015-04-16	Ebadi Mark A	Methods and compositions for symptomatic reflief of the common cold
HUE058904T2 (hu)	2014-05-07	2022-09-28	Boehringer Ingelheim Int	Porlasztókészülék
US10722666B2 (en)	2014-05-07	2020-07-28	Boehringer Ingelheim International Gmbh	Nebulizer with axially movable and lockable container and indicator
CA2948071C (en)	2014-05-07	2022-08-30	Boehringer Ingelheim International Gmbh	Container, nebulizer and use
EP3236933B1 (en)	2014-12-24	2018-11-14	JADRAN - GALENSKI LABORATORIJ d.d.	A nasal composition containing sea water as stability-improving excipient
MX383771B (es)	2015-12-02	2025-03-14	Pablo Cortes Borrego	Combinación de oximetazolina e ipratropio en aplicación tópica nasal para el tratamiento de la tos.
US20220031739A1 (en) *	2020-07-31	2022-02-03	Eye Therapies Llc	Anti-viral compositions and methods of use thereof
CN121868276A (zh) *	2022-10-25	2026-04-17	广东药科大学	托品酸及其衍生物在制备免疫与炎症相关疾病治疗药物中的医药用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2137981T3 (es) *	1991-11-19	2000-01-01	Univ Virginia	Tratamiento combinado por agentes antimediaticos y antiviricos de resfriados comunes.
IL101056A (en)	1992-02-24	1997-03-18	Res & Dev Co Ltd	Composition for nasal treatment
GB9218834D0 (en)	1992-09-05	1992-10-21	Procter & Gamble	Nasal spray products
ES2129117T3 (es) *	1992-12-09	1999-06-01	Boehringer Ingelheim Pharma	Formulaciones en disolucion en forma de aerosol medicinales estabilizadas.
EP0780127A1 (en)	1995-12-19	1997-06-25	The Procter & Gamble Company	A nasal spray containing a steroid and a antihistamine
DE19653969A1 (de) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
IL131492A0 (en) *	1997-04-30	2001-01-28	Warner Lambert Co	Topical nasal antiinflammatory compositions
WO1999038492A1 (en) *	1998-01-30	1999-08-05	Novartis Consumer Health S.A.	Nasal solutions
ATE253896T1 (de)	1998-06-18	2003-11-15	Boehringer Ingelheim Pharma	Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
CZ295595B6 (cs) *	1999-06-22	2005-08-17	Boehringer Ingelheim International Gmbh	Stálý roztok xylometazolinu a oxymetazolinu
DE60209511T2 (de) *	2001-09-18	2006-10-05	Nycomed Danmark Aps	Zusammensetzungen zur behandlung des schnupfens, welche ipratropium und xylometazolin enthalten

2002
- 2002-09-18 DE DE60209511T patent/DE60209511T2/de not_active Expired - Lifetime
- 2002-09-18 WO PCT/IB2002/003828 patent/WO2003024433A2/en not_active Ceased
- 2002-09-18 DK DK02765268T patent/DK1446119T3/da active
- 2002-09-18 JP JP2003528530A patent/JP4500045B2/ja not_active Expired - Lifetime
- 2002-09-18 US US10/489,655 patent/US7652030B2/en not_active Expired - Lifetime
- 2002-09-18 ES ES02765268T patent/ES2259098T3/es not_active Expired - Lifetime
- 2002-09-18 CA CA002460140A patent/CA2460140C/en not_active Expired - Lifetime
- 2002-09-18 NZ NZ531792A patent/NZ531792A/en not_active IP Right Cessation
- 2002-09-18 CN CNB028182871A patent/CN1290502C/zh not_active Expired - Lifetime
- 2002-09-18 PL PL370536A patent/PL208686B1/pl unknown
- 2002-09-18 BR BRPI0212586A patent/BRPI0212586B8/pt not_active IP Right Cessation
- 2002-09-18 KR KR1020047003882A patent/KR100810872B1/ko not_active Expired - Lifetime
- 2002-09-18 PT PT02765268T patent/PT1446119E/pt unknown
- 2002-09-18 EP EP06075452A patent/EP1661570A3/en not_active Withdrawn
- 2002-09-18 HU HU0402075A patent/HU226527B1/hu unknown
- 2002-09-18 EA EA200400444A patent/EA008165B1/ru unknown
- 2002-09-18 SI SI200230311T patent/SI1446119T1/sl unknown
- 2002-09-18 EP EP02765268A patent/EP1446119B1/en not_active Expired - Lifetime
- 2002-09-18 AT AT02765268T patent/ATE318601T1/de active
- 2002-09-18 MX MXPA04002500A patent/MXPA04002500A/es active IP Right Grant
2004
- 2004-03-12 NO NO20041070A patent/NO334441B1/no not_active IP Right Cessation
2009
- 2009-12-11 US US12/654,145 patent/US8450339B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NZ531792A (en)	2006-02-24
HU226527B1 (hu)	2009-03-30
EP1446119B1 (en)	2006-03-01
CN1555263A (zh)	2004-12-15
ATE318601T1 (de)	2006-03-15
EA200400444A1 (ru)	2005-02-24
HUP0402075A2 (hu)	2005-02-28
US8450339B2 (en)	2013-05-28
ES2259098T3 (es)	2006-09-16
DE60209511D1 (de)	2006-04-27
KR100810872B1 (ko)	2008-03-06
PL370536A1 (en)	2005-05-30
JP2005505569A (ja)	2005-02-24
US20100093783A1 (en)	2010-04-15
WO2003024433A2 (en)	2003-03-27
EP1661570A2 (en)	2006-05-31
EA008165B1 (ru)	2007-04-27
HUP0402075A3 (en)	2008-04-28
US20040248924A1 (en)	2004-12-09
WO2003024433A3 (en)	2004-06-10
BRPI0212586B8 (pt)	2021-05-25
DK1446119T3 (da)	2006-07-10
KR20040049849A (ko)	2004-06-12
EP1661570A3 (en)	2012-10-24
DE60209511T2 (de)	2006-10-05
US7652030B2 (en)	2010-01-26
CN1290502C (zh)	2006-12-20
HK1067984A1 (en)	2005-04-22
EP1446119A2 (en)	2004-08-18
PT1446119E (pt)	2006-07-31
PL208686B1 (pl)	2011-05-31
CA2460140A1 (en)	2003-03-27
CA2460140C (en)	2009-09-01
BR0212586B1 (pt)	2013-11-19
NO334441B1 (no)	2014-03-03
BR0212586A (pt)	2004-10-13
MXPA04002500A (es)	2004-11-22
JP4500045B2 (ja)	2010-07-14
SI1446119T1 (sl)	2006-08-31

Legal Events

Date	Code	Title	Description
2006-05-02	CREP	Change of representative	Representative=s name: PLOUGMANN & VINGTOFT POSTBOKS 1003 SENTRUM OSLO, 0
2016-02-22	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: TAKEDA PHARMA A/S, DK
2022-10-10	MK1K	Patent expired

Publication	Publication Date	Title
PL370536A1 (en)	2005-05-30	Compositions for treatment of common cold
WO2003009838A1 (en)	2003-02-06	Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
WO2002070510A3 (de)	2003-01-30	Aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
BR9812361A (pt)	2000-09-19	Uso de combinações compreendendo anti-histaminas não-sedantes e drogas alfa-adrenérgicas para o tratamento tópico de rinite/conjutivite e sintomas de infecção por vìrus, semelhante a infecção por vìrus e/ou resfriado
WO2002085909A8 (en)	2004-04-29	9-deazaguanine derivatives as inhibitors of gsk-3
BR0313176A (pt)	2005-06-14	Composições de pirazol úteis como inibidores de gsk-3
NO20042596L (no)	2004-06-21	Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
CA2460865A1 (en)	2003-04-10	Quinoline derivatives as neuropeptide y antagonists
SE0101932D0 (sv)	2001-05-31	Pharmaceutical combinations
WO2002088100A3 (de)	2003-05-30	Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
GB0222514D0 (en)	2002-11-06	Organic compounds
TW200626159A (en)	2006-08-01	Therapeutic combinations comprising poly (ADP-ribose) polymerases inhibitor
WO2003087049A3 (de)	2004-02-05	Arzneimittelkombinationen enthaltend heterocyclische verbindungen und ein neues anticholinergikum
TW200603787A (en)	2006-02-01	Topical preparations containing ambroxol
BR0212329A (pt)	2004-09-21	Métodos para tratar doença pulmonar
SE0102440D0 (sv)	2001-07-05	New compound
CA2433833A1 (en)	2002-07-25	Use of flumazenil in developing a drug for the treatment of alcohol dependence
NO20064811L (no)	2006-10-23	4-(5-aminometyl-2-fluor-fenyl)-piperidin-1-yl]-(4-brom-3-metyl-5-propoksy-tiofen-2-yl)-metanonhydroklorid som en inhibitor av mastcelletryptase
WO2002065989A3 (en)	2002-12-12	Aminoglycoside treatment for lysosomal storage diseases
EP1666064A4 (en)	2008-12-17	MEANS FOR THE TREATMENT OF DISEASES RELATED TO IMMUNOGLOBULIN GEN TRANSLATION
WO2005074983A3 (en)	2006-04-13	Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
WO2005039483A3 (en)	2005-09-29	Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
NO20024289D0 (no)	2002-09-09	Preparat for behandling av hjertesvikt
SE0000303D0 (sv)	2000-01-31	Novel compounds
PT1307192E (pt)	2006-06-30	Candesartan para tratamento da enxaqueca